The capacitive biosensor achieves rapid detection of H5N1 and E. coli, streamlining pathogen monitoring and enhancing ...

The reviewed studies examined the use of wearable devices - including smartwatches, fitness bands, and sensor-equipped ...

The biosensors market is being driven by a significant increase in chronic illnesses such as diabetes, a surge in research and development for biotechnology, and the surge in demand for homecare ...

Understand the significant growth trajectory of the Implantable Devices segment, which is expected to reach US$2.8 Billion by ...

For self-health monitoring, Blue Cloud Softech Solutions Limited (BCSSL) integrated biosensors with artificial intelligence ...

The availability of an FDA-approved OTC device could also reduce the risk ... and now is creating a new category by bringing the first glucose biosensor cleared for use over-the-counter ...

Biohacking combines science and lifestyle changes, offering strategies like intermittent fasting and sleep optimization to ...

The global US Remote Patient Monitoring Market, valued at US$14.15 billion in 2024, is forecasted to grow at a robust CAGR of 12.8%, reaching ...

The collective motion of bacteria—from stable swirling patterns to chaotic turbulent flows—has intrigued scientists for decades. When a bacterial swarm is confined in small circular space, stable ...

In today’s digital transformation era, the Internet of Things (IoT) has become a cornerstone of modern technology, revolutionizing industries through automation ...

Ova, a Western student-founded company, is developing a product to help women track hormonal changes, with a focus on addressing gaps in menstrual health.

Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.